Circ_0003645 serves as miR-335-5p sponge to promote the biological process of diffuse large B-cell lymphoma by upregulating NFIB
Authors:
- 8 January 2022
- journal article
- research article
- Published by Taylor & Francis in Autoimmunity
- Vol. 55 (2) , 127-135
Abstract
Circular RNAs (circRNAs) are critical regulators for the development of many tumours, including diffuse large B-cell lymphoma (DLBCL). However, the role and mechanism of circ_0003645 in DLBCL progr...Keywords
Funding Information
- Natural Science
- dation of Fujian Province (2020J011303, 2020J011299)
- Zhangzhou Natural Science Foundation Project (NO.ZZ020J05)
This publication has 28 references indexed in Scilit:
- NFIB promotes cell survival by directly suppressing p21 transcription in TP53‐mutated triple‐negative breast cancerThe Journal of Pathology, 2018
- Nuclear factor I/B promotes colorectal cancer cell proliferation, epithelial‐mesenchymal transition and 5‐fluorouracil resistanceCancer Science, 2018
- Diffuse large B-cell lymphomaPathology, 2018
- CircRNA: a novel type of biomarker for cancerBreast Cancer, 2017
- CircRNA: functions and properties of a novel potential biomarker for cancerMolecular Cancer, 2017
- Diffuse Large B-cell lymphoma: Prognostic markers and their impact on therapyExpert Review of Hematology, 2016
- Treatment of Diffuse Large B-Cell LymphomaJournal of Clinical and Experimental Hematopathology, 2016
- Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2015
- Relapsed/Refractory Diffuse Large B-Cell LymphomaHematology-American Society Hematology Education Program, 2011
- NFIB is a potential target for estrogen receptor‐negative breast cancersMolecular Oncology, 2011